会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 72. 发明专利
    • PROCESS FOR PRODUCTION OF NEW 12-AMINE-PIRIDAZINE/4'5': 3,4/-PIROLLO-ISOQUINOLINES AND MEDICAL COMPOUNDS CONTAINING THEM
    • HU196203B
    • 1988-10-28
    • HU18386
    • 1986-01-14
    • BOEHRINGER INGELHEIM KG
    • LOESEL WALTERREICHL RICHARDROOS OTTOSCHNORRENBERG GERDENSINGER HELMUT
    • A61K31/00A61K31/50A61P9/00A61P25/28C07D471/00C07D471/14A61K31/395
    • 1. Claims for the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE 12-Amino-pyridazino[4',5':3,4]pyrrolo[2,1-a]isoquinolines of general formula I see diagramm : EP0190563,P15,F1 wherein R1 and R2 , which may be identical or different, each represent hydrogen, C3-7 cycloalkyl, C2-5 alkenyl, phenyl (optionally mono- or disubstituted by halogen atoms or methoxy groups), propargyl, a straight-chained or branched, saturated or unsaturated alkyl group with 1 to 5 carbon atoms which may be substituted by hydroxy, alkoxy with 1 to 4 carbon atoms, halogen, NH2 , NH-alkyl with 1 to 2 carbon atoms, N,N-dialkyl with 1 to 2 carbon atoms, NH-acyl with 2 to 4 carbon atoms, cycloalkyl with 3 to 7 carbon atoms, phenyl (optionally substituted by halogen, alkyl with 1 to 2 carbon atoms, alkoxy with 1 to 2 carbon atoms, NH-alkyl with 1 to 2 carbon atoms, N,N-dialkyl with 1 to 2 carbon atoms, NH2 , N-acyl with 2 to 3 carbon atoms), furyl, thienyl, a nitrogen-containing heterocyclic 5- or 6-membered ring which may optionally contain as a further heteroatom an oxygen or sulphur atom (and the ring may optionally be substituted by alkyl with 1 to 4 carbon atoms), or R1 and R2 together with the nitrogen atom represent a 3- to 7-membered ring which may optionally contain as a further heteroatom an oxygen or nitrogen atom [the ring may be optionally substituted by phenyl (C1-4 ) alkyl (this phenyl ring in turn being mono- or disubstituted by halogen atoms or methoxy groups)], or R2 , if R1 represents hydrogen, represents -NH2 , di(C1-2 ) alkylamino, acetonylamino, -NH(C2-3 ) acyl, alkylsulphonyl or alkyloxycarbonyl group with 1 to 3 carbon atoms in the alkyl chain, a isopropylideneimino group see diagramm : EP0190563,P15,F2 or a heterocyclic 5- or 6-membered ring containing a nitrogen atom and optionally containing as a further heteroatom an oxygen, nitrogen or sulphur atom, R3 , R4 and R5 , which may be identical or different, represent hydrogen or alkyl groups with 1 to 4 carbon atoms, R7 and R8 , which may be identical or different, represent hydroxy, alkoxy with 1 to 4 carbon atoms or alkylthio groups with 1 to 4 carbon atoms, and R6 and R9 , which may be identical or different, represent hydrogen, hydroxy, alkoxy with 1 to 4 carbon atoms or alkylthio groups with 1 to 4 carbon atoms or a group see diagramm : EP0190563,P16,F1 wherein R10 represents hydrogen or alkyl with 1 to 4 carbon atoms and R11 represents alkyl with 1 to 4 carbon atoms any such alkyl group being optionally substituted by a hydroxy, methoxy or furfuryl group and physiologically acceptable acid addition salts thereof. 1. Claims for the Contracting State : AT Process for preparing a 12-amino-pyridazino[4',5':3,4]pyrrolo[2,1-a]isoquinoline of general formula see diagramm : EP0190563,P17,F1 wherein R1 and R2 , which may be identical or different, each represent hydrogen, C3-7 cycloalkyl, C2-5 alkenyl, phenyl (optionally mono- or disubstituted by halogen atoms or methoxy groups), propargyl, a straight-chained or branched, saturated or unsaturated alkyl group with 1 to 5 carbon atoms which may be substituted by hydroxy, alkoxy with 1 to 4 carbon atoms, halogen, NH2 , NH-alkyl with 1 to 2 carbon atoms, N,N-dialkyl with 1 to 2 carbon atoms, NH-acyl with 2 to 4 carbon atoms, cycloalkyl with 3 to 7 carbon atoms, phenyl (optionally substituted by halogen, alkyl with 1 to 2 carbon atoms, alkoxy with 1 to 2 carbon atoms, NH-alkyl with 1 to 2 carbon atoms, N,N-dialkyl with 1 to 2 carbon atoms, NH2 , N-acyl with 2 to 3 carbon atoms), furyl, thienyl, a nitrogen-containing heterocyclic 5- or 6-membered ring which may optionally contain as a further heteroatom an oxygen or sulphur atom (and the ring may optionally be substituted by alkyl with 1 to 4 carbon atoms), or R1 and R2 together with the nitrogen atom represent a 3- to 7-membered ring which may optionally contain as a further heteroatom an oxygen or nitrogen atom [the ring may optionally be substituted by phenyl (C1-4 ) alkyl (this phenyl ring in turn being mono- or disubstituted by halogen atoms or methoxy groups)], or R2 , if R1 represents hydrogen, represents -NH2 , di(C1-2 ) alkylamino, acetonylamino, -NH(C2-3 ) acyl, alkylsulphonyl or alkyloxycarbonyl group with 1 to a carbon atoms in the alkyl chain, a isopropylideneimino group see diagramm : EP0190563,P17,F2 or a heterocyclic 5- or 6-membered ring containing a nitrogen atom and optionally containing as a further heteroatom an oxygen, nitrogen or sulphur atom, R3 , R4 and R5 , which may be identical or different, represent hydrogen or alkyl groups with 1 to 4 carbon atoms, R7 and R8 , which may be identical or different, represent hydroxy, alkoxy with 1 to 4 carbon atoms or alkylthio groups with 1 to 4 carbon atoms, and R6 and R9 , which may be identical or different, represent hydrogen, hydroxy, alkoxy with 1 to 4 carbon atoms or alkylthio groups with 1 to 4 carbon atoms or a group see diagramm : EP0190563,P17,F3 wherein R10 represents hydrogen or alkyl with 1 to 4 carbon atoms and R11 represents alkyl with 1 to 4 carbon atoms any such alkyl group being optionally substituted by a hydroxy, methoxy or furfuryl group or a physiologically acceptable acid addition salt thereof, characterised in that a 3,4-dihydro-12-methyl-mercapto- pyridazino[4',5':3,4]pyrrolo[2,1-a]isoquinoline of general formula II see diagramm : EP0190563,P18,F1 wherein the groups R3 , R4 , R5 , R6 , R7 , R8 and R9 are as hereinbefore defined, is reacted with a compound of general formula III see diagramm : EP0190563,P18,F2 wherein R1 and R2 are as hereinbefore defined, and in that a compound thus obtained is optionally converted, in a manner known per se, into a physiologically acceptable acid addition salt.
    • 75. 发明专利
    • DD258612A5
    • 1988-07-27
    • DD29418186
    • 1986-09-05
    • BOEHRINGER INGELHEIM KG
    • ROSS OTTOSCHNORRENBERG GERDLOESEL WALTERWIEDEMANN INGRIDGAIDA WOLFRAMHOEFKE WOLFGANG
    • C07K14/81A61K38/00A61K38/55A61P9/12A61P43/00C07K1/113C07K5/06C07K5/068A61K37/64
    • The amino acid derivatives have the general formula in which R is H, acetyl, benzoyl, pivaloyl or the radical P is one of the numbers 1-4; A is a residue of one of the alpha -amino acids or R2 is hydrogen, C1-C4-alkyl, straight-chain or branched, C5-C7-cycloalkyl, it being possible for a phenyl ring to be fused on, phenyl, phenyl-C1-C4-alkyl, a hetero-C1-C4-alkyl radical where the heterocycle consists of a 5- or 6-membered ring with 1-2 of the hetero atoms O, S or N, R3 is hydrogen, C1-C4-alkyl, straight-chain or branched, phenyl, phenyl-C1-C4-alkyl or a hetero-C1-C4-alkyl radical where the heterocycle consists of a 5- or 6-membered ring with 1-2of the hetero atoms O, S or N, or R2 and R3 together form with the N and the C atom a 5-, 6- or 7-membered ring which can be saturated or contain one double bond, or a 4-, 5- or 6-membered ring which contains one or more of the hetero atoms O, S or N; R4 is OH, C1-C4- omega -hydroxyalkyl, C1-C4-alkoxy, phenyl-C1-C4-alkoxy, C1-C4-alkylamino, (C1-C4)2-dialkylamino, one of the groups or an alpha -amino acid which is linked in the manner of a peptide to the CO group of the molecule; R5 is C1-C4-alkyl, C1-C3-alkenyl, C1-C3-alkynyl, straight-chain or branched, hydroxyl, nitro, amino, C1-C4-alkoxy, mercapto, C1-C4- alkylthio, hydroxy-C1-C4-alkyl, mercapto-C1-C4-alkyl, F, Cl, Br, amino-C1-C4-alkyl, sulphonamido, methylenedioxy, fluoro-C1-C4-alkyl, chloro-C1-C4-alkyl, bromo-C1-C4-alkyl, cyano or trifluoromethyl; R6 is hydrogen or methyl; R7 is C1-C4-alkyl, straight-chain or branched, where the alkyl radical can be substituted by F, Cl, Br, CF3, phenyl or pyridyl; X, Y and Z are O, S, NR8, CR9, CHR9, with the proviso that only one of the radicals X, Y and Z can be O, S, and one or two of the radicals X, Y and Z can be NR8; R8 is hydrogen or C1-C4-alkyl, straight-chain or branched; R9 is hydrogen or, together with a vicinal radical R9, a phenyl ring or, for m and n = 1, the dihydro form thereof with double bond in conjugation with the C-terminal carboxyl group and m and n are each 0, 1 or 2, where the total of m and n is 1 or 2. The compounds are strong inhibitors of angiotensin I converting enzyme and are intended for use as hypotensive agents.
    • 76. 发明专利
    • PROCESS FOR PREPARING DERIVATIVES OF AMINOACIDS
    • CS255896B2
    • 1988-03-15
    • CS714185
    • 1985-10-04
    • BOEHRINGER INGELHEIM KG
    • ROOS OTTOSCHNORRENBERG GERDLOESEL WALTERWIEDEMANN INGRIDGAIDA WOLFGANGHOEFKE WOLFGANG
    • C07K14/81A61K38/00A61K38/55A61P9/12A61P43/00C07K1/113C07K5/06C07K5/068C07K5/00C07C101/00
    • The amino acid derivatives have the general formula in which R is H, acetyl, benzoyl, pivaloyl or the radical P is one of the numbers 1-4; A is a residue of one of the alpha -amino acids or R2 is hydrogen, C1-C4-alkyl, straight-chain or branched, C5-C7-cycloalkyl, it being possible for a phenyl ring to be fused on, phenyl, phenyl-C1-C4-alkyl, a hetero-C1-C4-alkyl radical where the heterocycle consists of a 5- or 6-membered ring with 1-2 of the hetero atoms O, S or N, R3 is hydrogen, C1-C4-alkyl, straight-chain or branched, phenyl, phenyl-C1-C4-alkyl or a hetero-C1-C4-alkyl radical where the heterocycle consists of a 5- or 6-membered ring with 1-2of the hetero atoms O, S or N, or R2 and R3 together form with the N and the C atom a 5-, 6- or 7-membered ring which can be saturated or contain one double bond, or a 4-, 5- or 6-membered ring which contains one or more of the hetero atoms O, S or N; R4 is OH, C1-C4- omega -hydroxyalkyl, C1-C4-alkoxy, phenyl-C1-C4-alkoxy, C1-C4-alkylamino, (C1-C4)2-dialkylamino, one of the groups or an alpha -amino acid which is linked in the manner of a peptide to the CO group of the molecule; R5 is C1-C4-alkyl, C1-C3-alkenyl, C1-C3-alkynyl, straight-chain or branched, hydroxyl, nitro, amino, C1-C4-alkoxy, mercapto, C1-C4- alkylthio, hydroxy-C1-C4-alkyl, mercapto-C1-C4-alkyl, F, Cl, Br, amino-C1-C4-alkyl, sulphonamido, methylenedioxy, fluoro-C1-C4-alkyl, chloro-C1-C4-alkyl, bromo-C1-C4-alkyl, cyano or trifluoromethyl; R6 is hydrogen or methyl; R7 is C1-C4-alkyl, straight-chain or branched, where the alkyl radical can be substituted by F, Cl, Br, CF3, phenyl or pyridyl; X, Y and Z are O, S, NR8, CR9, CHR9, with the proviso that only one of the radicals X, Y and Z can be O, S, and one or two of the radicals X, Y and Z can be NR8; R8 is hydrogen or C1-C4-alkyl, straight-chain or branched; R9 is hydrogen or, together with a vicinal radical R9, a phenyl ring or, for m and n = 1, the dihydro form thereof with double bond in conjugation with the C-terminal carboxyl group and m and n are each 0, 1 or 2, where the total of m and n is 1 or 2. The compounds are strong inhibitors of angiotensin I converting enzyme and are intended for use as hypotensive agents.
    • 77. 发明专利
    • METHOD OF AMINO ACIDS' DERIVATIVES PRODUCTION
    • CS254345B2
    • 1988-01-15
    • CS624285
    • 1985-09-02
    • BOEHRINGER INGELHEIM KG
    • ROOS OTTOLOESEL WALTERSCHNORRENBERG GERDWIEDEMANN INGRIDGAIDA WOLFRAMHOEFKE WOLFGANG
    • C07D495/04A61K31/401A61K31/435A61K38/00A61K38/05A61K38/55A61P9/12A61P43/00C07K1/113C07K5/06C07K5/062C07K14/81C07K7/04
    • The derivatives have the general formula in which R1 is H, phenyl, benzyl, phenethyl; R2 is H, acetyl, benzoyl, 3-sulphonamido-4-chlorobenzoyl, 3-sulphonamido-4-chloro-6-hydroxybenzoyl, 3-sulphonamido-4-chloro-5-[(furyl)amino]benzoyl, 2,3-dichloro-4-( beta -phenylacryloyl) phenoxyacetyl, pivaloyl, C1-C2-alkylaminocarbonyl, C1-C2-alkylaminothiocarbonyl, acyl or the radical A is the residue of one of the alpha -amino acids or R3 is hydrogen, C1-C4-alkyl, straight-chain or branched, C5-C7-cycloalkyl, it being possible for a phenyl ring to be fused on, phenyl, phenyl-C1-C4-alkyl, a hetero-C1-C4-alkyl radical where the heterocycle consists of a 5- or 6-membered ring with 1-2 of the hetero atoms O, S or N, R4 is hydrogen, C1-C4-alkyl, straight-chain or branched, phenyl, phenyl-C1-C4-alkyl or a hetero-C1-C4-alkyl radical where the heterocycle consists of a 5- or 6-membered ring with 1-2 of the hetero atoms O, S or N, or R3 and R4 together form with the N and the C atom a 5-, 6- or 7-membered ring which can be saturated or contain one double bond, or a 4-, 5- or 6-membered ring which contains one or two more of the hetero atoms O, S or N; R5 is OH, C1-C4- omega -hydroxyalkoxy, C1-C4-alkoxy, phenyl-C1-C4-alkoxy, C1-C4-alkylamino, (C1-C4)2-dialkylamino, one of the groups or an alpha -amino acid which is linked in the manner of a peptide to the CO group of the molecule; R6 is C1-C4-alkyl, C1-C3-alkenyl, C1-C3-alkynyl, straight-chain or branched, hydroxyl, nitro, amino, C1-C4-alkoxy, mercapto, C1-C4- alkylthio, hydroxy-C1-C4-alkyl,mercapto-C1-C4-alkyl, F, Cl, Br, amino-C1-C4-alkyl, sulphonamido, methylenedioxy, fluoro-C1-C4-alkyl, chloro-C1-C4-alkyl, bromo-C1-C4-alkyl, cyano or trifluoromethyl; R7 is hydrogen or methyl; R8 is C1-C4-alkyl, straight-chain or branched, where the alkyl radical can be substituted by F, Cl, Br, CF3, phenyl or pyridyl; X, Y and Z are O, S, CR10, CHR10, with the proviso that only one of the radicals X, Y and Z can be O, S, and one or two radicals X, Y and Z can be NR9; R9 is hydrogen or C1-C4-alkyl, straight-chain or branched; R10 is hydrogen or, together with a vicinal radical R10, a phenyl ring or, for m and n = 1, the dihydro form thereof with the double bond in conjugation with the C-terminal carboxyl group and m and n are each 0, 1 or 2, where the total of m and n is 1 or 2, and are strong inhibitors of angiotensin I converting enzyme and are intended for use as hypotensive agents.